GAP INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GAP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $15.37B | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $15.09B | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | $14.89B | Mar 17, 2026 |
| FY2024 | Jan 28, 2023 | $15.62B | Mar 18, 2025 |
| FY2023 | Jan 29, 2022 | $16.67B | Mar 19, 2024 |
| FY2022 | Jan 30, 2021 | $13.80B | Mar 14, 2023 |
| FY2019 | Feb 1, 2020 | $4.67B | Mar 17, 2020 |
| FY2019 | Nov 2, 2019 | $4.00B | Mar 17, 2020 |
| FY2019 | Aug 3, 2019 | $4.01B | Mar 17, 2020 |
| FY2019 | May 4, 2019 | $3.71B | Mar 17, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Feb 3, 2018 | $4.78B | Mar 20, 2018 |
| FY2017 | Oct 28, 2017 | $3.84B | Mar 20, 2018 |
| FY2017 | Jul 29, 2017 | $3.80B | Mar 20, 2018 |
| FY2017 | Apr 29, 2017 | $3.44B | Mar 20, 2018 |
| FY2017 | Jan 28, 2017 | $4.43B | Mar 20, 2018 |
| FY2017 | Oct 29, 2016 | $3.80B | Mar 20, 2018 |
| FY2017 | Jul 30, 2016 | $3.85B | Mar 20, 2018 |
| FY2017 | Apr 30, 2016 | $3.44B | Mar 20, 2018 |
| FY2016 | Jan 30, 2016 | $4.39B | Mar 20, 2017 |
| FY2016 | Oct 31, 2015 | $3.86B | Mar 20, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $6.27B | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $6.23B | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | $5.78B | Mar 17, 2026 |
| FY2024 | Jan 28, 2023 | $5.36B | Mar 18, 2025 |
| FY2023 | Jan 29, 2022 | $6.64B | Mar 19, 2024 |
| FY2022 | Jan 30, 2021 | $4.71B | Mar 14, 2023 |
| FY2019 | Feb 1, 2020 | $1.67B | Mar 17, 2020 |
| FY2019 | Nov 2, 2019 | $1.56B | Mar 17, 2020 |
| FY2019 | Aug 3, 2019 | $1.56B | Mar 17, 2020 |
| FY2019 | May 4, 2019 | $1.34B | Mar 17, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $816.00M | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $844.00M | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | $502.00M | Mar 17, 2026 |
| FY2024 | Jan 28, 2023 | ($202.00M) | Mar 18, 2025 |
| FY2023 | Jan 29, 2022 | $256.00M | Mar 19, 2024 |
| FY2022 | Jan 30, 2021 | ($665.00M) | Mar 14, 2023 |
| FY2019 | Feb 1, 2020 | ($184.00M) | Mar 17, 2020 |
| FY2019 | Nov 2, 2019 | $140.00M | Mar 17, 2020 |
| FY2019 | Aug 3, 2019 | $168.00M | Mar 17, 2020 |
| FY2019 | May 4, 2019 | $227.00M | Mar 17, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.12B | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $1.11B | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | $560.00M | Mar 17, 2026 |
| FY2024 | Jan 28, 2023 | ($69.00M) | Mar 18, 2025 |
| FY2023 | Jan 29, 2022 | $810.00M | Mar 19, 2024 |
| FY2022 | Jan 30, 2021 | ($862.00M) | Mar 14, 2023 |
| FY2021 | Feb 1, 2020 | $574.00M | Mar 15, 2022 |
| FY2020 | Feb 2, 2019 | $1.36B | Mar 16, 2021 |
| FY2019 | Feb 3, 2018 | $1.48B | Mar 17, 2020 |
| FY2018 | Jan 28, 2017 | $1.19B | Mar 19, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $60.00M | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $40.00M | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | $37.00M | Mar 17, 2026 |
| FY2024 | Jan 28, 2023 | $46.00M | Mar 18, 2025 |
| FY2023 | Jan 29, 2022 | $41.00M | Mar 19, 2024 |
| FY2022 | Jan 30, 2021 | $46.00M | Mar 14, 2023 |
| FY2021 | Feb 1, 2020 | $41.00M | Mar 15, 2022 |
| FY2020 | Feb 2, 2019 | $50.00M | Mar 16, 2021 |
| FY2019 | Feb 3, 2018 | $51.00M | Mar 17, 2020 |
| FY2018 | Jan 28, 2017 | $46.00M | Mar 19, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.29B | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $1.49B | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | $1.53B | Mar 17, 2026 |
| FY2024 | Jan 28, 2023 | $607.00M | Mar 18, 2025 |
| FY2023 | Jan 29, 2022 | $809.00M | Mar 19, 2024 |
| FY2022 | Jan 30, 2021 | $237.00M | Mar 14, 2023 |
| FY2021 | Feb 1, 2020 | $1.41B | Mar 15, 2022 |
| FY2020 | Feb 2, 2019 | $1.38B | Mar 16, 2021 |
| FY2019 | Feb 3, 2018 | $1.38B | Mar 17, 2020 |
| FY2018 | Jan 28, 2017 | $1.72B | Mar 19, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $470.00M | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $447.00M | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | $420.00M | Mar 17, 2026 |
| FY2024 | Jan 28, 2023 | $685.00M | Mar 18, 2025 |
| FY2023 | Jan 29, 2022 | $694.00M | Mar 19, 2024 |
| FY2022 | Jan 30, 2021 | $392.00M | Mar 14, 2023 |
| FY2021 | Feb 1, 2020 | $702.00M | Mar 15, 2022 |
| FY2020 | Feb 2, 2019 | $705.00M | Mar 16, 2021 |
| FY2019 | Feb 3, 2018 | $731.00M | Mar 17, 2020 |
| FY2018 | Jan 28, 2017 | $524.00M | Mar 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $12.63B | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $11.89B | Mar 17, 2026 |
| FY2024 | Feb 3, 2024 | $11.04B | Mar 18, 2025 |
| FY2023 | Jan 28, 2023 | $11.39B | Mar 19, 2024 |
| FY2022 | Jan 29, 2022 | $12.76B | Mar 14, 2023 |
| FY2021 | Jan 30, 2021 | $13.77B | Mar 15, 2022 |
| FY2020 | Feb 1, 2020 | $13.68B | Mar 16, 2021 |
| FY2019 | Feb 2, 2019 | $8.05B | Mar 17, 2020 |
| FY2018 | Feb 3, 2018 | $7.99B | Mar 19, 2019 |
| FY2017 | Jan 28, 2017 | $7.61B | Mar 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $3.80B | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $3.26B | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | $2.60B | Mar 17, 2026 |
| FY2025 | Jan 28, 2023 | $2.23B | Mar 17, 2026 |
| FY2024 | Jan 29, 2022 | $2.72B | Mar 18, 2025 |
| FY2023 | Jan 30, 2021 | $2.61B | Mar 19, 2024 |
| FY2022 | Feb 1, 2020 | $3.32B | Mar 14, 2023 |
| FY2021 | Feb 2, 2019 | $3.55B | Mar 15, 2022 |
| FY2020 | Feb 3, 2018 | $3.14B | Mar 16, 2021 |
| FY2019 | Jan 28, 2017 | $2.90B | Mar 17, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $207.00M | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $207.00M | Mar 17, 2026 |
| FY2024 | Feb 3, 2024 | $207.00M | Mar 18, 2025 |
| FY2023 | Jan 28, 2023 | $207.00M | Mar 19, 2024 |
| FY2022 | Jan 29, 2022 | $207.00M | Mar 14, 2023 |
| FY2021 | Jan 30, 2021 | $109.00M | Mar 15, 2022 |
| FY2020 | Feb 1, 2020 | $109.00M | Mar 16, 2021 |
| FY2019 | Feb 2, 2019 | $109.00M | Mar 17, 2020 |
| FY2018 | Feb 3, 2018 | $109.00M | Mar 19, 2019 |
| FY2017 | Jan 28, 2017 | $109.00M | Mar 20, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $3.61B | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $3.04B | Mar 17, 2026 |
| FY2024 | Feb 3, 2024 | $2.42B | Mar 18, 2025 |
| FY2023 | Jan 28, 2023 | $2.14B | Mar 19, 2024 |
| FY2022 | Jan 29, 2022 | $2.62B | Mar 14, 2023 |
| FY2021 | Jan 30, 2021 | $2.50B | Mar 15, 2022 |
| FY2020 | Feb 1, 2020 | $3.26B | Mar 16, 2021 |
| FY2019 | Feb 2, 2019 | $3.48B | Mar 17, 2020 |
| FY2018 | Feb 3, 2018 | $3.08B | Mar 19, 2019 |
| FY2017 | Jan 28, 2017 | $2.75B | Mar 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $2.62B | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | $2.34B | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | $1.87B | Mar 17, 2026 |
| FY2024 | Jan 28, 2023 | $1.22B | Mar 18, 2025 |
| FY2023 | Jan 29, 2022 | $877.00M | Mar 19, 2024 |
| FY2022 | Jan 30, 2021 | $1.99B | Mar 14, 2023 |
| FY2021 | Feb 1, 2020 | $1.36B | Mar 15, 2022 |
| FY2020 | Feb 2, 2019 | $1.08B | Mar 16, 2021 |
| FY2019 | Feb 3, 2018 | $1.78B | Mar 17, 2020 |
| FY2017 | Jan 28, 2017 | $1.78B | Mar 20, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Feb 3, 2018 | $1.25B | Mar 20, 2018 |
| FY2017 | Jan 28, 2017 | $1.31B | Mar 20, 2018 |
| FY2016 | Jan 30, 2016 | $1.33B | Mar 20, 2017 |
| FY2015 | Jan 31, 2015 | $1.35B | Mar 21, 2016 |
| FY2014 | Feb 1, 2014 | $1.39B | Mar 23, 2015 |
| FY2013 | Feb 2, 2013 | $1.25B | Mar 24, 2014 |
| FY2012 | Jan 28, 2012 | $1.65B | Mar 26, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 2 | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | 2 | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | 1 | Mar 17, 2026 |
| FY2024 | Jan 28, 2023 | 0 | Mar 18, 2025 |
| FY2023 | Jan 29, 2022 | 0 | Mar 19, 2024 |
| FY2022 | Jan 30, 2021 | (1) | Mar 14, 2023 |
| FY2019 | Feb 1, 2020 | 0 | Mar 17, 2020 |
| FY2019 | Nov 2, 2019 | 0 | Mar 17, 2020 |
| FY2019 | Aug 3, 2019 | 0 | Mar 17, 2020 |
| FY2019 | May 4, 2019 | 0 | Mar 17, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 2 | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | 2 | Mar 17, 2026 |
| FY2025 | Feb 3, 2024 | 1 | Mar 17, 2026 |
| FY2024 | Jan 28, 2023 | 0 | Mar 18, 2025 |
| FY2023 | Jan 29, 2022 | 0 | Mar 19, 2024 |
| FY2022 | Jan 30, 2021 | (1) | Mar 14, 2023 |
| FY2019 | Feb 1, 2020 | 0 | Mar 17, 2020 |
| FY2019 | Nov 2, 2019 | 0 | Mar 17, 2020 |
| FY2019 | Aug 3, 2019 | 0 | Mar 17, 2020 |
| FY2019 | May 4, 2019 | 0 | Mar 17, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 372.00M | Mar 17, 2026 |
| FY2025 | Feb 1, 2025 | 374.00M | Mar 17, 2026 |
| FY2024 | Feb 3, 2024 | 372.00M | Mar 18, 2025 |
| FY2023 | Jan 28, 2023 | 366.00M | Mar 19, 2024 |
| FY2022 | Jan 29, 2022 | 371.00M | Mar 14, 2023 |
| FY2021 | Jan 30, 2021 | 374.00M | Mar 15, 2022 |
| FY2020 | Feb 1, 2020 | 371.00M | Mar 16, 2021 |
| FY2019 | Feb 2, 2019 | 378.00M | Mar 17, 2020 |
| FY2018 | Feb 3, 2018 | 389.00M | Mar 19, 2019 |
| FY2017 | Jan 28, 2017 | 399.00M | Mar 20, 2018 |